Blockade of atrial angiotensin II type 1 receptors - A novel antiarrhythmic strategy to prevent atrial fibrillation?

被引：16
|
作者：
Klein, HU [1 ]
Goette, A [1 ]
机构：
[1] Univ Hosp Magdeburg, Dept Internal Med, Div Cardiol, D-39120 Magdeburg, Germany
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2003年 / 41卷 / 12期
关键词：
D O I：
10.1016/S0735-1097(03)00469-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2205 / 2206
页数：2
相关论文
共 50 条
  • [21] Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?
    Mascolo, Annamaria
    Urbanek, Konrad
    De Angelis, Antonella
    Sessa, Maurizio
    Scavone, Cristina
    Berrino, Liberato
    Rosano, Giuseppe Massimo Claudio
    Capuano, Annalisa
    Rossi, Francesco
    HEART FAILURE REVIEWS, 2020, 25 (02) : 367 - 380
  • [22] Memantine targets glutamate receptors in atrial cardiomyocytes to prevent and treat atrial fibrillation
    Duanyang Xie
    Ke Xiong
    Xuling Su
    Guanghua Wang
    Luxin Wang
    Qicheng Zou
    Caihong Zhang
    Yuting Cao
    Yi Liu
    Yi-Han Chen
    Cell Discovery, 8
  • [23] Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation?
    Annamaria Mascolo
    Konrad Urbanek
    Antonella De Angelis
    Maurizio Sessa
    Cristina Scavone
    Liberato Berrino
    Giuseppe Massimo Claudio Rosano
    Annalisa Capuano
    Francesco Rossi
    Heart Failure Reviews, 2020, 25 : 897 - 897
  • [24] Renin-angiotensin-aldosterone system blockade in atrial fibrillation and left atrial remodelling
    Krishnamoorthy, S.
    Lip, G. Y. H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (07) : 982 - 985
  • [25] Renin–angiotensin blockade in atrial fibrillation: where are we now?
    F Shahid
    G Y H Lip
    E Shantsila
    Journal of Human Hypertension, 2017, 31 : 425 - 426
  • [26] Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation
    Kumagai, K
    Nakashima, H
    Urata, H
    Gondo, N
    Arakawa, K
    Saku, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) : 2197 - 2204
  • [27] Dual blockade of endothelin A and angiotensin II type 1 receptors with sparsentan as a novel treatment strategy to alleviate IgA nephropathy
    Nagasawa, Hajime
    Suzuki, Hitoshi
    Ueda, Seiji
    Suzuki, Yusuke
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (11) : 1143 - 1152
  • [28] Inhibition of angiotensin II type I receptors affects atrial fibrillation susceptibility and myocardial interstitial fibrosis in goats
    Karalis, I. K.
    Chrysostomakis, S. I.
    Simantirakis, E. N.
    Koutsopoulos, A.
    Mavrakis, H. E.
    Vardas, P. E.
    EUROPEAN HEART JOURNAL, 2007, 28 : 155 - 155
  • [29] Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties
    Nattel, S
    Liu, LL
    St-Georges, D
    CARDIOVASCULAR RESEARCH, 1998, 37 (03) : 627 - 635
  • [30] Angiotensin inhibitors prevent atrial fibrillation after cardiothoracic surgery
    Kalus, James S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A15 - A15
12345